This is a prospective, interventional, double-blinded placebo-controlled study of up to 40 participants to evaluate the effect of a botanical formulation on inflammatory and cardiovascular biomarkers .
The objective of this study is to understand the impact of a multi-botanical formulation on measurements of protein markers, with a focus on inflammation over a 60-day period. The primary objective of this study is to assess the effect of the formulation, LLP-01, on inflammatory and cardiovascular proteomic biomarkers. Adverse events will be self-monitored by participants and will be reported. Changes in weight/calculated BMI and grip strength, as well as changes in well-being through a self-reported questionnaire will also be measured.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
OTHER
Masking
DOUBLE
Enrollment
32
LL Prosper Inc.
San Diego, California, United States
Plasma Proteomic Changes
Serum proteomic test to measure significant effects on any of the plasma proteins that will be analyzed. These proteins represent inflammatory, and cardiovascular responses, as well as metabolic functions.
Time frame: Change from baseline to 60 days and compared to placebo
Grip Strength
Digital grip strength device to measure absolute grip strength
Time frame: Change from baseline to 60 days and compared to placebo
Weight/BMI
Height and weight to measuring absolute weight and to calculate BMI
Time frame: Change from baseline to 60 days and compared to placebo
Well-being
Questionnaire covering different aspects of well-being
Time frame: Change from baseline to 60 days and compared to placebo
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.